Review Papers Claim by Claim

Visual paper analysis — "A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3"

This review focuses on the paper's experimental design, evidence for translation and secretion of circCCDC7-180aa, functional phenotypes, the proposed FLRT3-mediated mechanism, and key limitations & reproducibility risks. Visualize-first; explain-second.

Figure 1 — Experimental-sample map (counts per assay)

Figure 2 — Evidence chain: from circular RNA to secreted peptide

Key strengths (visual bullets)

• Multimodal evidence: molecular validation (RNase R, junction PCR, Sanger), ribosome association, mass-spectrometry peptide evidence, and functional genetics (frame-shift mutation abolishing activity) are all presented — strengthening the claim of translation and function circCCDC7 multimodal evidence
• Mechanistic downstream link: FLRT3 identified as downstream mediator; FLRT3 knockdown rescues circCCDC7 effects, providing functional epistasis support (downstream necessity) FLRT3 epistasis evidence

Major limitations & blindspots (visual matrix)

• Small discovery set: discovery RNA-seq used six tumor foci from three patients — this is underpowered to detect frequent, heterogeneous circRNA events across patients and increases false discovery risk Small discovery cohort
• Overexpression caveats: many functional readouts rely on lentiviral overexpression of circCCDC7 or linear ORFs — overexpression can saturate pathways and produce non-physiologic secretion/localization levels; endogenous translation quantitation (ribosome density, absolute peptide copies per cell) is not fully quantified.
• Mechanism incompletely resolved: FLRT3 is shown necessary downstream but the receptor or membrane partner for secreted circCCDC7-180aa and the transcriptional/ post-transcriptional route by which FLRT3 is upregulated are not biochemically demonstrated.
• Platform detection bias: TCGA polyA-selected libraries failed to detect circCCDC7 (authors note), illustrating detection-dependence on library prep and potential ascertainment bias for circRNAs in public cohorts.

Context with prior work: circRNA translation & functional peptides

The idea that circRNAs can encode functional peptides is increasingly supported by independent studies across tissues and systems. Two representative references:

• Functional circRNA–protein complexes / noncoding mechanisms: circ-Foxo3 forms ternary complexes (RNA–protein) to regulate the cell cycle, demonstrating noncoding circRNA functions can be direct and mechanistic rather than via peptide coding; contrasts with protein-coding circRNAs but shows mechanistic diversity of circRNAs circ-Foxo3 ternary complex
• Local translation of circRNAs in brain plasticity: learning-induced local translation of synapse-enriched circRNAs and MS-validated circRNA peptides (e.g., P1) show circRNA-derived peptides can be biologically active in vivo in sensitive contexts, supporting plausibility of circCCDC7-180aa secretion & function Synaptic circRNA translation study

Interpretation & confidence levels

What is well supported (confidence ~0.7/1): circCCDC7 exists as a circular RNA (RNase R resistant, junction-validated), has translation potential (ribosome association; IRES predictions), and overexpression of the circ-derived ORF produces a secreted 180aa protein with tumor-suppressive effects in multiple cell lines and xenograft models Functional phenotype evidence

What is tentative (confidence ~0.4–0.6/1): the precise endogenous abundance of circCCDC7-180aa and whether physiological (not overexpressed) levels suffice to alter FLRT3 in human tumors; the direct receptor or molecular binding partner for the secreted peptide hasn't been biochemically characterized; clinical translation remains speculative.

What experiments would most convincingly falsify or confirm the model?

1. Endogenous loss-of-function in patient-derived organoids or xenografts using BSJ-targeted Gapmers/CRISPR-Cas13/siRNA: show that knocking down circCCDC7 (without affecting linear CCDC7 mRNA) increases proliferation/migration and reduces FLRT3 — this would confirm physiological relevance.
2. Quantitative proteomics (absolute peptide quantification, e.g., parallel-reaction-monitoring) for the junction peptide in clinical tumors and plasma to show endogenous peptide abundance and secretion at physiologic levels.
3. Biochemical receptor identification (affinity purification of membrane proteins using recombinant circCCDC7-180aa bait + crosslinking, followed by MS) to demonstrate direct binding partner and downstream signaling pathway connecting peptide binding to FLRT3 upregulation.
4. Knock-in of an epitope-tagged circCCDC7 ORF at the endogenous locus in prostate cancer cell lines (CRISPR) to observe translation & secretion under native expression control.

Practical recommendations for authors / follow-up work

• Provide absolute quantification of the circ-encoded peptide in cells, conditioned media, and patient samples (targeted MS) to bridge overexpression-to-physiology gap.
• Perform endogenous-loss-of-function (BSJ-targeting) experiments and rescue with peptide-only expression to demonstrate protein sufficiency and RNA dispensability.
• Map peptide–protein interactors on cell surface (crosslink + pulldown MS) to test the receptor hypothesis rather than inferring indirect regulation of FLRT3.
• Share raw quantitative data and sequences (read-level circRNA alignments, MS spectra) in accessible repositories to aid reproducibility (authors provided GSA accession for overexpression data; request the clinical RNA-seq reads for independent reanalysis) Data availability statement

Bottom-line assessment

The paper substantially advances evidence that at least some human circRNAs encode biologically active peptides that can be secreted and alter tumor biology; the multimodal evidence is persuasive, but the study is limited by small clinical discovery sets, dependence on overexpression, and incomplete mechanistic biochemistry linking the secreted peptide to FLRT3 induction. Replication with endogenous perturbations, targeted quantitation, and receptor identification are the clearest next steps.

Key citations used in this review (every claim above is grounded in the following primary sources):

• circCCDC7 prostate cancer paper
• circ-Foxo3 ternary complex
• Synaptic circRNA translation study